Eurofins Financial Statements From 2010 to 2024
| ERF Stock | EUR 47.41 0.45 0.96% |
Check Eurofins Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Eurofins Scientific's main balance sheet or income statement drivers, such as , as well as many indicators such as . Eurofins financial statements analysis is a perfect complement when working with Eurofins Scientific Valuation or Volatility modules.
Eurofins |
Eurofins Scientific SE Company Shares Outstanding Analysis
Eurofins Scientific's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current Eurofins Scientific Shares Outstanding | 192.56 M |
Most of Eurofins Scientific's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Eurofins Scientific SE is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
Based on the latest financial disclosure, Eurofins Scientific SE has 192.56 M of shares currently outstending. This is 6.66% higher than that of the Healthcare sector and 34.94% higher than that of the Diagnostics & Research industry. The shares outstanding for all France stocks is 66.32% higher than that of the company.
Eurofins Scientific Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Eurofins Scientific's current stock value. Our valuation model uses many indicators to compare Eurofins Scientific value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Eurofins Scientific competition to find correlations between indicators driving Eurofins Scientific's intrinsic value. More Info.Eurofins Scientific SE is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.49 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Eurofins Scientific SE is roughly 2.03 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Eurofins Scientific by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Eurofins Scientific's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.About Eurofins Scientific Financial Statements
Eurofins Scientific stakeholders use historical fundamental indicators, such as Eurofins Scientific's revenue or net income, to determine how well the company is positioned to perform in the future. Although Eurofins Scientific investors may analyze each financial statement separately, they are all interrelated. For example, changes in Eurofins Scientific's assets and liabilities are reflected in the revenues and expenses on Eurofins Scientific's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Eurofins Scientific SE. Please read more on our technical analysis and fundamental analysis pages.
Eurofins Scientific SE, through its subsidiaries, provides various analytical testing services worldwide. The company was founded in 1987 and is headquartered in Luxembourg City, Luxembourg. EUROFINS SCIENT operates under Diagnostics Research classification in France and is traded on Paris Stock Exchange. It employs 43819 people.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Eurofins Stock
Eurofins Scientific financial ratios help investors to determine whether Eurofins Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Eurofins with respect to the benefits of owning Eurofins Scientific security.